Patent · US Active

Anti-VEGFR-3 antibody compositions

US8481034B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 1, 2011
Grant dateJul 9, 2013
Priority date
Expiry dateFeb 2, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides anti-VEGFR-3 monoclonal antibodies, pharmaceutical compositions containing said antibodies and uses of said antibodies in the treatment of disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.